Clinical Trials Browser

Phase 2 × Epstein-Barr Virus Infections × Rituximab × Clear all

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Phase 2 Completed

94 enrolled 20 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT00267865 2020-06-01

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Phase 2 Completed

12 enrolled 15 charts

Acquired Immunodeficiency Syndrome, Epstein-Barr Virus Infections

NCT01136395 2019-10-08

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Phase 2 Completed

Virus Diseases, Epstein-Barr Virus Infections

NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Phase 2 Terminated

6 enrolled 14 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

NCT01058239 2018-02-15

Bortezomib Plus Rituximab for EBV+ PTLD

Phase 2 Completed

7 enrolled 15 charts

Epstein-Barr Virus Infections